Skip to main content

Day: May 9, 2022

Locafy Exceeds $500k Monthly Revenue Milestone as Product Take-Up Accelerates

Key HighlightsLocafy achieved more than a $500,000 in revenue for the first time in April 2022, more than 130% YoY growth from April 2021 Locafy Reseller numbers more than tripled in the current financial year to now exceed 100 in April as the company continues its focus on growing its channel partner network in North America, UK and Australia Net new customer numbers continued to grow across channel and direct salesPERTH, AUSTRALIA, May 09, 2022 (GLOBE NEWSWIRE) — Operations Update Locafy had 103 Resellers at the end of April, more than 3.5x the number of Resellers at the start of the Australian financial year, which commenced July 1, 2021.  Resellers are a key part of our plans to drive revenue growth. The onboarding of a large number in the last 11 months highlights the increasing interest and confidence around our product...

Continue reading

Emergia Inc. Announces Filing of Its 2021 Financial Statements

MONTREAL, May 09, 2022 (GLOBE NEWSWIRE) — (CSE: EMER) Emergia Inc. (the “Corporation” or “EMERGIA”) announces today that it has filed, its audited annual financial statements, ‎management’s discussion and analysis and its Annual Report, and related certifications for the fiscal year ended December ‎‎31, 2021. “Emergia has passed the crucial stages of its strategic restructuring plan implemented last year. Its thorough execution has resulted in a significant improvement in the Corporation’s balance sheet, particularly by its deleverage, and increase in the total assets value, as shown in the financial statements. These results thus prove the strength and soundness of our plan, which allowed to improve remarkably the financial situation of the Corporation compared to 2020” said Henri Petit, Chief Executive Officer of the Corporation. The...

Continue reading

Finch Therapeutics to Host Corporate Update Conference Call and Webcast on May 16, 2022

SOMERVILLE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs, today announced it will host a conference call and live webcast on Monday, May 16, 2022 at 8:00am ET to discuss updates to its development programs and other business highlights. The conference call can be accessed by dialing (833) 649-1186 (domestic) or (270) 823-1080 (international) and entering conference ID 8451806. The live webcast can be accessed by visiting the ‘Investors & News’ section of the Finch Therapeutics website and selecting ‘Events & Presentations’. The webcast will be archived on the Finch website for approximately...

Continue reading

University of Tennessee Health Science Center Leverages CareCloud’s Technology to Enhance Revenues and Streamline Workflows

SOMERSET, N.J., May 09, 2022 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that the University of Tennessee Health Science Center, College of Dentistry Pathology, has selected CareCloud’s Revenue Cycle Services and talkEHR to enhance revenues, streamline workflows, and alleviate billing inefficiencies. The University of Tennessee is the seventh university specializing in oral pathology to select CareCloud’s cloud-based technology and the second university to select CareCloud this month. “We look forward to helping the University of Tennessee increase profitability with our digital, secure and flexible billing and EHR system,” said Al Nardi SVP Strategy, CareCloud. “The University evaluated a number...

Continue reading

Plusgrade to Acquire Points in an All Cash Transaction

All outstanding common shares of Points to be acquired for US$25.00 per share TORONTO, May 09, 2022 (GLOBE NEWSWIRE) — Points.com Inc. (TSX: PTS) (NASDAQ: PCOM) (“Points” or the “Company”), the global leader in powering loyalty commerce, is pleased to announce that it has entered into an arrangement agreement (the “Arrangement Agreement”) pursuant to which a wholly-owned subsidiary (the “Purchaser”) of Plusgrade Parent L.P. (“Plusgrade”), a leading ancillary revenue platform for the global travel industry, will acquire all of the issued and outstanding common shares of the Company for US$25.00 per common share in cash (equivalent to C$32.21 assuming a 1.2882 exchange rate as per the Bank of Canada May 6 noon rate) (the “Consideration”) by way of a statutory plan of arrangement under the Canada Business Corporations Act (the “Transaction”). The...

Continue reading

VSBLTY REPORTS 2021 EARNINGS

Philadelphia, PA, May 09, 2022 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (OTCQB: VSBGF) (CSE: VSBY) (Frankfurt 5VS) (“VSBLTY”), a leading software provider of security and retail analytics technology, today announced its revenue for 2021 was $1.6 million (USD), which is a 164 percent increase over the previous year of $607K. VSBLTY technology provides enhanced customer engagement and audience measurement using machine learning and computer vision. Its industry leading VisionCaptor™ and DataCaptor™ software combine motion graphics and interactive brand messaging with cutting-edge computer vision measurement and insights. VSBLTY’s AI driven software Vector™ provides enhanced facial recognition that is crucial to strengthening today’s security requirements when recognizing weapons or suspicious persons in a crowd. The...

Continue reading

Recreational Vehicle Market Size to Hit USD 87.89 Billion by 2028 | Industry Share, Growth and Trends Analysis Report

According to Fortune Business Insights, the global Recreational Vehicle market size is projected to grow from USD 55.90 billion in 2021 to USD 87.89 billion in 2028, at CAGR of 6.7% during forecast period; Strong Demand for Comfortable Travel & Accommodation to Foster Industry Development Pune, India, May 09, 2022 (GLOBE NEWSWIRE) — The recreational vehicle market size was valued at USD 55.28 billion in 2020. The market is estimated to grow from USD 55.90 billion in 2021 to USD 87.89 billion in 2028, exhibiting a CAGR of 6.7% during the forecast period. Rising active campers and robust demand for comfortable travel & accommodation are expected to foster market development. Fortune Business Insights™ presents this information in its report titled “Recreational Vehicle Market, 2021-2028.” Recreational vehicles are automobiles...

Continue reading

High Voltage Cables Market Size [2021-2026] to Hit USD 54.97 Billion | Industry Trends, Growth, Share and Forecast Analysis

Surge in Need to Replace Old Grid Infrastructures with New Ones to Aid in Expansion of Global High Voltage Cables MarketHigh Voltage Cables Market Size Global High Voltage Cables Market SizePune, India, May 09, 2022 (GLOBE NEWSWIRE) — The global high voltage cables market size is projected to grow from USD 31.89 billion in 2018 to USD 54.97 billion in 2026, at CAGR of 7.11% during forecast period; Rapid urbanization witnessed worldwide to boost global high voltage cables market growth. On the basis of installation, the overhead installation segment is dominating the market because of the low transmission losses and easy installation processes. The report is based on an in-depth analysis of the high voltage cables market. It offers details about major factors propelling and repelling growth, along with major high voltage cables...

Continue reading

Vaxxinity Reports First Quarter 2022 Financial Results and Provides Corporate Updates

DALLAS, May 09, 2022 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the first quarter ended March 31, 2022. “Vaxxinity has laid the groundwork to have multiple shots on goal this year after a productive and exciting start to 2022. The FDA granted Fast Track designation to our Alzheimer’s vaccine candidate and we completed enrollment for our Parkinson’s vaccine candidate with initial data expected in the second half of this year. We also initiated enrollment in our global pivotal Phase 3 trial of UB-612 for prevention of COVID-19 with the support of a CEPI grant,” said Mei Mei Hu, CEO of Vaxxinity. “As we pursue our mission to democratize health and bring transformative medicines to all patients in need,...

Continue reading

Adaptimmune Reports First Quarter Financial Results and Business Update

– Pooled data from Cohort 1 of the SPEARHEAD-1 trial and the Phase 1 trial of afami-cel in patients with sarcoma to be presented as a poster at ASCO – – Preclinical data for two novel next-generation T-cell therapies to be presented in two posters at ASGCT – – Updated MAGE-A4 expression levels from the Company’s screening protocol presented at AACR confirm the potential of this target in a broad range of solid tumors – – Appointed Jo Brewer as Chief Scientific Officer – – Financial guidance confirmed: funded into early 2024 – – Conference call to be held today at 8:00 a.m. EDT (1:00 p.m. BST) – PHILADELPHIA and OXFORDSHIRE, United Kingdom, May 09, 2022 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in cell therapy to treat cancer,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.